Skip to main content

Advised by Leo Meggitt, Managing Director, Mastella Advisory

We advise UK owners of care home groups and domiciliary / live-in care businesses on confidential sales. Senior-led, off-market, in the £5–50M EV segment.

Part of Healthcare services · All sectors

Who we work with

You own a UK care home group or a domiciliary / live-in care business worth between £5M and £50M in enterprise value. A regional residential or nursing care group of three to fifteen homes. A domiciliary care business with hourly and live-in services. A specialist provider (complex needs, dementia, learning disability, mental health residential). Most likely some combination of private-pay, Local Authority funded and CCG / ICB contracted revenue.

The buyer pool is segmented. PE-backed consolidators dominate domiciliary care acquisitions. Larger strategic care operators acquire across both residential and domiciliary. Freehold-heavy residential portfolios attract a separate property-led buyer pool — REIT-style investors, OpCo/PropCo specialists, and infrastructure-style capital — willing to pay premium pricing for the property and lease the operating business back. The right process design unlocks both pools simultaneously.

We engage 12 to 24 months before a target exit. The longer window matters because the highest-return preparation work in care — addressing CQC standing across every site, documenting occupancy and payer mix trajectories, surfacing payment model performance, and (for freehold-heavy portfolios) preparing the property and operating business to be sold separately or together — takes time.

This is not the right fit if your business is below £5M EV, or if CQC standing is unresolved at material sites. In both cases the readiness phase comes first. It is also not the right fit if you are committed to a specific bilateral approach already; that is a different mandate.

What buyers look for

Buyer diligence in UK care M&A focuses on six items. Each is fixable in advance, and each consistently drives the difference between top-of-range and median-multiple outcomes.

CQC standing first. Outstanding-rated portfolios attract premium pricing. Requires Improvement or Inadequate ratings are usually fixable but materially affect both buyer appetite and price if unaddressed. We typically advise addressing remediable CQC issues 6 to 12 months before any process so the rating is settled by the time the data room opens.

Occupancy and FTE clients second. For residential care, average occupancy across the portfolio and per-site is the headline. For domiciliary care, FTE clients, weekly hours delivered, and client retention. Premium pricing requires consistent occupancy above 88-90% in residential and stable FTE client growth in domiciliary.

Payer mix third. The split between private-pay, Local Authority funded, CCG / ICB funded and NHS funded revenue determines both the buyer pool and the multiple. Higher private and CCG-funded revenue generally supports stronger multiples; LA-funded revenue is predictable but margin-constrained. We help owners present payer mix and average weekly rates honestly and in the right comparative context.

Property structure fourth. Freehold-heavy residential portfolios open the property-led buyer pool in addition to the operating buyer pool. We typically run the process to maximise outcome from both pools simultaneously, with OpCo/PropCo structuring where it produces a better total outcome.

Carer and nurse retention fifth. The single biggest operational risk in this sector and a primary diligence concern. Buyers look at carer tenure, training depth, agency-usage ratios, and wage benchmarks against the regional market. Premium pricing requires a credible retention story.

Local Authority and CCG contract novation sixth. We map the contractual position on every material LA/CCG/ICB contract, flagging any novation or consent requirements ahead of time so they can be planned around rather than becoming a late-stage surprise.

Our process

Our six-stage process runs senior-led from first conversation to completion. For care, three things shape execution.

Regulated and contractual diligence sit on longer clocks than commercial diligence. CQC reports across every site, LA / CCG / ICB contract novation, property and lease diligence, and (for any open commissioning matters) ongoing dialogue with commissioners. We build all of this into the process design from the start.

Buyer mapping covers two distinct pools simultaneously: operating acquirers (PE consolidators and strategic operators) and property-led acquirers. The right process design surfaces interest from both, often producing the strongest total outcome through an OpCo/PropCo structure rather than a single-pool sale. Our buyer mapping is supported by our proprietary technology layer for surfacing acquirer signals.

Carer and senior team engagement is structured into the process design from the start. Get this wrong and the deal stalls; get it right and the buyer pays for the team alongside the assets. See the healthcare services pillar for context and mental health services for the closest specialist niche.

Considering a sale of your care home and domiciliary care business?

Book a confidential conversation

FAQ

Selling a care home and domiciliary care business: FAQs

What multiples do UK care home and domiciliary care businesses trade at?

Care home groups typically trade at 8–12x EBITDA depending on quality (CQC standing), occupancy, payer mix and property arrangements. Domiciliary care businesses typically trade at 6–9x EBITDA, with premium multiples for specialist or complex-needs providers.

How does the property structure (freehold vs leasehold) affect a sale?

Buyers approach freehold-heavy and leasehold-heavy portfolios very differently. Freehold-heavy assets often attract a separate property-led buyer pool (REIT-style and OpCo/PropCo specialists), in addition to operating buyers. We help owners design the process to maximise outcome from each pool.

How does CQC standing affect valuation?

Materially. Outstanding-rated portfolios attract strong premium pricing. Inadequate or Requires Improvement ratings are usually fixable but materially affect both buyer appetite and price if unaddressed.

Who buys UK care home and domiciliary care businesses?

PE-backed consolidators (very active in domiciliary care), larger strategic operators, property-led investors for freehold-heavy portfolios, and overseas strategics for selected platforms.

How long does a care sector sale typically take?

6–9 months end to end. CQC and Local Authority notifications and contract novation can extend timelines.

What about payer mix (LA vs private vs NHS)?

Payer mix is one of the first diligence items. Higher private and CCG-funded revenue generally supports stronger multiples. LA-funded revenue is highly predictable but margin-constrained.

15+

Years in M&A

£400M+

Transaction value advised

30+

Completed transactions

10

Sectors

Your care home and domiciliary care transaction starts with a conversation.

Forty-five minutes, no obligation. We will tell you honestly whether what you want to achieve is realistic — and whether Mastella is the right firm for it.

AlignedWe work on a high monthly retainer model that funds senior-led delivery throughout — not a commission structure that rewards getting any deal done.

Book a confidential conversation